Gain- and loss-of-function studies indicate that insulin resistance or hyperglycemia-induced downregulation of IRS1 elevates KLF4 expression, a transcriptional repressor of the smooth muscle contractile phenotype. This evidence concerns the gene IRS1 and Insulin resistance.